Heart disease is the major cause of death in industrialized societies. Lifestyle changes and the many drugs available to reduce LDL cholesterol have done a great deal to reduce heart disease, and the major avenue to further therapeutic progress lies in learning how to raise HDL, a major protection against heart disease. The mouse is an excellent model for finding HDL genes because the quantitative trait loci (QTL) for HDL in mouse and human are found in concordant locations. During the last grant period, we searched for and identified many genes that underlie HDL QTL using newly developed bioinformatic resources and methods as well as the classic genetic approaches for narrowing QTL. We also obtained preliminary evidence that many of the QTL genes for HDL fall into two biological pathways: the reverse cholesterol transport pathway and the metabolic syndrome pathway. In this renewal, we propose to test the hypothesis that these two pathways are highly significant in HDL regulation and to identify many more of the genes involved. In connection with our bioinformatics work, we developed a new standard genetic map for the mouse by correcting the mismapped MIT markers and demonstrating that recalculating QTLs with the new map caused a significant percentage of QTLs to move by more than 10 cM. Therefore, the first aim of this proposal is to recalculate the QTL data for at least 24 HDL crosses and as many more as possible. During the last grant period, we also carried out a meta-analysis for HDL QTL combining all crosses from the literature. The results showed that 38 loci had combined LOD scores that reached significance;we have identified the QTL genes for about half of these loci. In this grant period our second aim will be to identify additional QTL genes starting with the most significant and working our way down the list. As we identify each additional QTL gene, we will determine how it fits into pathways of HDL metabolism. Of the QTL genes that we have tentatively identified, several have a known function in HDL metabolism but others are quite new, and the mechanisms by which they modulate HDL levels are completely unknown. Therefore in aim 3 we propose to obtain additional evidence by making genetically engineered models of these genes, either transgenes or knockouts/knockins.

Public Health Relevance

to human health The major goal is to identify the genes and pathways that affect HDL cholesterol, which provides protection against the leading cause of death, heart disease. Identifying these HDL genes will uncover novel drug targets, and understanding the pathways of HDL regulation will elucidate the drug targets likely to have the greatest impact on HDL. Raising HDL is predicted to decrease heart disease incidence.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL077796-09
Application #
8278057
Study Section
Genetics of Health and Disease Study Section (GHD)
Program Officer
Liu, Lijuan
Project Start
2004-07-01
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
9
Fiscal Year
2012
Total Cost
$430,650
Indirect Cost
$183,150
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Morgan, Judith L; Svenson, Karen L; Lake, Jeffrey P et al. (2014) Effects of housing density in five inbred strains of mice. PLoS One 9:e90012
Choi, Seungbum; Aljakna, Aleksandra; Srivastava, Ujala et al. (2013) Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9. Lipids Health Dis 12:112
Leduc, Magalie S; Blair, Rachael Hageman; Verdugo, Ricardo A et al. (2012) Using bioinformatics and systems genetics to dissect HDL-cholesterol genetics in an MRL/MpJ x SM/J intercross. J Lipid Res 53:1163-75
Hageman, Rachael S; Leduc, Magalie S; Korstanje, Ron et al. (2011) A Bayesian framework for inference of the genotype-phenotype map for segregating populations. Genetics 187:1163-70
Leduc, Magalie S; Lyons, Malcolm; Darvishi, Katayoon et al. (2011) The mouse QTL map helps interpret human genome-wide association studies for HDL cholesterol. J Lipid Res 52:1139-49
Leduc, Magalie S; Hageman, Rachael S; Verdugo, Ricardo A et al. (2011) Integration of QTL and bioinformatic tools to identify candidate genes for triglycerides in mice. J Lipid Res 52:1672-82
Su, Zhiguang; Leduc, Magalie S; Korstanje, Ron et al. (2010) Untangling HDL quantitative trait loci on mouse chromosome 5 and identifying Scarb1 and Acads as the underlying genes. J Lipid Res 51:2706-13
Su, Zhiguang; Wang, Xiaosong; Tsaih, Shirng-Wern et al. (2009) Genetic basis of HDL variation in 129/SvImJ and C57BL/6J mice: importance of testing candidate genes in targeted mutant mice. J Lipid Res 50:116-25
Shockley, Keith R; Witmer, David; Burgess-Herbert, Sarah L et al. (2009) Effects of atherogenic diet on hepatic gene expression across mouse strains. Physiol Genomics 39:172-82
Burgess-Herbert, Sarah L; Tsaih, Shirng-Wern; Stylianou, Ioannis M et al. (2009) An experimental assessment of in silico haplotype association mapping in laboratory mice. BMC Genet 10:81

Showing the most recent 10 out of 12 publications